Global Antimicrobial Susceptibility Testing Market Size Study, by Product (Manual Tests, Automated Instruments, Consumables & Media), by Technique (Disk Diffusion, Automated AST, Etest Method, Others), by Application (Drug Development, Susceptibility Testing, Others), by End-use (Hospitals, Diagnostic Laboratories, Biotechnology & Pharmaceutical Companies, Others), and Regional Forecasts 2022-2032

January 2025 | 285 pages | ID: GF150CADFA1AEN
Bizwit Research & Consulting LLP

Abstracts

The global Antimicrobial Susceptibility Testing (AST) market, valued at USD 3.42 billion in 2023, is projected to reach USD 5.35 billion by 2032, growing at a robust CAGR of 5.1% during the forecast period from 2024 to 2032. AST plays a pivotal role in combating antimicrobial resistance (AMR), a growing global health crisis caused by the overuse and misuse of antibiotics. This testing method enables healthcare providers to identify the most effective antimicrobial therapy, minimizing treatment failures and the spread of resistant pathogens.

The market's expansion is driven by the rising incidence of drug-resistant infections and an increasing focus on personalized medicine, where tailored treatments demand precise diagnostic solutions like AST. Government initiatives, such as the U.S. National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB) and the Global Antibiotic Resistance and Usage Surveillance System (GLASS), are further bolstering the adoption of AST technologies. These efforts reflect the global commitment to reducing AMR through improved diagnostics and therapeutic strategies.

Technological advancements, particularly in automated AST systems, are reshaping the industry landscape. Automated systems offer higher accuracy, reduced errors, and faster turnaround times compared to manual methods. Recent innovations, such as rapid AST solutions capable of delivering results within hours, are accelerating their adoption in clinical and research settings. Companies like NanoSynex Ltd. and COPAN Diagnostics are at the forefront, introducing next-generation AST tools to the market.

Regional dynamics reveal North America as the dominant market, supported by advanced healthcare infrastructure, a high prevalence of multidrug-resistant infections, and substantial investments in R&D. Meanwhile, the Asia-Pacific region is expected to exhibit the fastest growth, driven by increasing healthcare expenditures, growing awareness of AMR, and initiatives to modernize healthcare systems. Europe also plays a significant role, benefiting from supportive policies and a focus on technological innovation.

________________________________________

Major market players included in this report are:

• Thermo Fisher Scientific Inc.
• BD (Becton, Dickinson, and Company)
• bioMйrieux SA
• Danaher Corporation
• Bio-Rad Laboratories Inc.
• Merck & Co., Inc.
• Siemens Healthineers
• Creative Diagnostics
• F. Hoffmann-La Roche Ltd
• Hi-Media Laboratories Pvt. Ltd.
• ELITechGroup
• COPAN Diagnostics Inc.
• Agilent Technologies Inc.
• Beckman Coulter Inc.
• NanoSynex Ltd.

________________________________________

The detailed segments and sub-segments of the market are explained below:

By Product:

• Manual Tests
• MIC Strips
• Susceptibility Testing Disks
• Susceptibility Plates
• Automated Instruments
• Consumables & Media

By Technique:

• Disk Diffusion
• Automated AST
• Etest Method
• Dilution
• Others

By Application:

• Drug Development
• Susceptibility Testing
• Others

By End-Use:

• Hospitals
• Diagnostic Laboratories
• Biotechnology & Pharmaceutical Companies
• Others

By Region:

• North America:
• U.S.
• Canada
• Europe:
• U.K.
• Germany
• France
• Spain
• Italy
• Sweden
• Norway
• Denmark
• Asia-Pacific:
• China
• India
• Japan
• South Korea
• Australia
• Thailand
• Latin America:
• Brazil
• Mexico
• Argentina
• Middle East & Africa:
• Saudi Arabia
• South Africa
• UAE
• Kuwait

________________________________________

Years considered for the study are as follows:

• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional-level analysis for each market segment.
• Detailed analysis of geographical landscape with country-level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approaches.
• Analysis of the competitive structure of the market.
• Demand-side and supply-side analysis of the market.

Contents

CHAPTER 1. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET EXECUTIVE SUMMARY

1.1. Global Antimicrobial Susceptibility Testing Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
  1.3.1. By Product
  1.3.2. By Technique
  1.3.3. By Application
  1.3.4. By End-Use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendations & Conclusion

CHAPTER 2. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET DEFINITION AND RESEARCH ASSUMPTIONS

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
  2.3.1. Inclusion & Exclusion
  2.3.2. Limitations
  2.3.3. Supply-Side Analysis
    2.3.3.1. Availability
    2.3.3.2. Infrastructure
    2.3.3.3. Regulatory Environment
    2.3.3.4. Market Competition
    2.3.3.5. Economic Viability (Consumer’s Perspective)
  2.3.4. Demand-Side Analysis
    2.3.4.1. Regulatory Frameworks
    2.3.4.2. Technological Advancements
    2.3.4.3. Environmental Considerations
    2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

CHAPTER 3. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET DYNAMICS

3.1. Market Drivers
  3.1.1. Increasing prevalence of antimicrobial resistance
  3.1.2. Advancements in personalized medicine
  3.1.3. Favorable government policies to combat AMR
3.2. Market Challenges
  3.2.1. High costs of advanced AST systems
  3.2.2. Limited standardization in AST techniques
3.3. Market Opportunities
  3.3.1. Expansion of rapid AST technologies
  3.3.2. Rising investments in healthcare infrastructure, especially in APAC

CHAPTER 4. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET INDUSTRY ANALYSIS

4.1. Porter’s Five Forces Model
  4.1.1. Bargaining Power of Suppliers
  4.1.2. Bargaining Power of Buyers
  4.1.3. Threat of New Entrants
  4.1.4. Threat of Substitutes
  4.1.5. Competitive Rivalry
4.2. PESTEL Analysis
  4.2.1. Political
  4.2.2. Economic
  4.2.3. Social
  4.2.4. Technological
  4.2.5. Environmental
  4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Disruptive Trends
4.5. Industry Expert Perspectives

CHAPTER 5. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE & FORECASTS BY PRODUCT (2022-2032)

5.1. Segment Dashboard
5.2. Manual Tests
  5.2.1. MIC Strips
  5.2.2. Susceptibility Testing Disks
  5.2.3. Susceptibility Plates
5.3. Automated Instruments
5.4. Consumables & Media

CHAPTER 6. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE & FORECASTS BY TECHNIQUE (2022-2032)

6.1. Segment Dashboard
6.2. Disk Diffusion
6.3. Automated AST
6.4. Etest Method
6.5. Others

CHAPTER 7. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE & FORECASTS BY APPLICATION (2022-2032)

7.1. Segment Dashboard
7.2. Drug Development
7.3. Susceptibility Testing
7.4. Others

CHAPTER 8. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE & FORECASTS BY END-USE (2022-2032)

8.1. Segment Dashboard
8.2. Hospitals
8.3. Diagnostic Laboratories
8.4. Biotechnology & Pharmaceutical Companies
8.5. Others

CHAPTER 9. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE & FORECASTS BY REGION (2022-2032)

9.1. North America
  9.1.1. U.S.
  9.1.2. Canada
9.2. Europe
  9.2.1. U.K.
  9.2.2. Germany
  9.2.3. France
  9.2.4. Spain
  9.2.5. Italy
  9.2.6. Sweden
  9.2.7. Norway
  9.2.8. Denmark
9.3. Asia-Pacific
  9.3.1. China
  9.3.2. India
  9.3.3. Japan
  9.3.4. South Korea
  9.3.5. Australia
  9.3.6. Thailand
9.4. Latin America
  9.4.1. Brazil
  9.4.2. Mexico
  9.4.3. Argentina
9.5. Middle East & Africa
  9.5.1. Saudi Arabia
  9.5.2. South Africa
  9.5.3. UAE
  9.5.4. Kuwait

CHAPTER 10. COMPETITIVE INTELLIGENCE

10.1. Key Company SWOT Analysis
  10.1.1. Thermo Fisher Scientific Inc.
  10.1.2. BD (Becton, Dickinson, and Company)
  10.1.3. bioMйrieux SA
10.2. Top Market Strategies
10.3. Company Profiles
  10.3.1. Thermo Fisher Scientific Inc.
  10.3.2. BD (Becton, Dickinson, and Company)
  10.3.3. Danaher Corporation
  10.3.4. Bio-Rad Laboratories Inc.
  10.3.5. Merck & Co., Inc.
  10.3.6. Siemens Healthineers
  10.3.7. Creative Diagnostics
  10.3.8. COPAN Diagnostics Inc.
  10.3.9. ELITechGroup
  10.3.10. Hi-Media Laboratories Pvt. Ltd.

CHAPTER 11. RESEARCH PROCESS

11.1. Research Process
  11.1.1. Data Mining
  11.1.2. Analysis
  11.1.3. Market Estimation
  11.1.4. Validation
11.2. Research Attributes

12. LIST OF TABLES

1. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE & FORECAST, 2022–2032 (USD BILLION)

2. NORTH AMERICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE & FORECAST BY COUNTRY, 2022–2032 (USD MILLION)

3. EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE & FORECAST BY COUNTRY, 2022–2032 (USD MILLION)

4. ASIA-PACIFIC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE & FORECAST BY COUNTRY, 2022–2032 (USD MILLION)

5. LATIN AMERICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE & FORECAST BY COUNTRY, 2022–2032 (USD MILLION)

6. MIDDLE EAST & AFRICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SIZE & FORECAST BY COUNTRY, 2022–2032 (USD MILLION)

7. MARKET SEGMENTATION BY PRODUCT, 2022–2032 (USD MILLION)

8. MANUAL TESTS MARKET SIZE & FORECAST, 2022–2032 (USD MILLION)

9. AUTOMATED INSTRUMENTS MARKET SIZE & FORECAST, 2022–2032 (USD MILLION)

10. CONSUMABLES & MEDIA MARKET SIZE & FORECAST, 2022–2032 (USD MILLION)

11. MARKET SEGMENTATION BY TECHNIQUE, 2022–2032 (USD MILLION)

12. DISK DIFFUSION MARKET SIZE & FORECAST, 2022–2032 (USD MILLION)

13. AUTOMATED AST MARKET SIZE & FORECAST, 2022–2032 (USD MILLION)

14. ETEST METHOD MARKET SIZE & FORECAST, 2022–2032 (USD MILLION)

15. MARKET SEGMENTATION BY APPLICATION, 2022–2032 (USD MILLION)

16. DRUG DEVELOPMENT MARKET SIZE & FORECAST, 2022–2032 (USD MILLION)

17. SUSCEPTIBILITY TESTING MARKET SIZE & FORECAST, 2022–2032 (USD MILLION)

18. END-USE MARKET SEGMENTATION BY HOSPITALS, 2022–2032 (USD MILLION)

19. BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES MARKET SIZE & FORECAST, 2022–2032 (USD MILLION)

20. LIST OF MAJOR MARKET PLAYERS AND MARKET SHARE ANALYSIS (2023)

This list is not complete; the final report contains over 100 tables. The list may be updated in the final deliverable.

12. LIST OF FIGURES

1. GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET TRENDS, 2022–2032

2. MARKET SEGMENTATION BY PRODUCT, 2023 (SHARE %)

3. REGIONAL ANALYSIS OF ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, 2023 (SHARE %)

4. MARKET SEGMENTATION BY TECHNIQUE, 2023 (SHARE %)

5. AUTOMATED INSTRUMENTS GROWTH RATE (CAGR) BY REGION, 2024–2032

6. TECHNOLOGICAL ADVANCEMENTS IN AST SYSTEMS, 2023 OVERVIEW

7. NORTH AMERICA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, HISTORICAL VS. FORECAST, 2022–2032

8. APAC ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET GROWTH POTENTIAL, 2023–2032

9. PORTER’S FIVE FORCES ANALYSIS OF THE AST MARKET, 2023

10. PESTEL ANALYSIS OF ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, 2023

11. COMPETITIVE MARKET SHARE ANALYSIS, 2023

12. SWOT ANALYSIS OF THERMO FISHER SCIENTIFIC INC.

13. SWOT ANALYSIS OF BD (BECTON, DICKINSON, AND COMPANY)

14. SWOT ANALYSIS OF BIOMЙRIEUX SA

15. TOP STRATEGIES OF KEY PLAYERS IN THE AST MARKET, 2023

16. GLOBAL AMR STATISTICS OVERVIEW, 2023 (CASES BY REGION)

17. SHARE OF AUTOMATED INSTRUMENTS VS. MANUAL TESTS, 2023

18. ROLE OF AST IN DRUG DEVELOPMENT PIPELINE, 2023–2032

19. REGIONAL SNAPSHOT OF KEY MARKET TRENDS, 2023

20. INVESTMENT TRENDS IN AST TECHNOLOGIES, 2024–2032

This list is not complete; the final report contains over 50 figures. The list may be updated in the final deliverable.